Lasharyl Barton-Collum
Psychiatric/Mental Health · Flower Mound, TXNPI 1245868249
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 923 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 923 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Johnson & Johnson$2K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$1K
- plus $5K from 27 others
What the payments were for
- Food & beverage$16,105100%
- Education$690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 120 | $2,340 |
| Johnson & Johnson | 101 | $2,090 |
| Otsuka America Pharmaceutical, Inc. | 143 | $1,813 |
| AbbVie | 134 | $1,728 |
| Alkermes, Inc. | 66 | $1,619 |
| Neurocrine Biosciences, Inc. | 58 | $1,378 |
| Lundbeck LLC | 62 | $1,042 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $811 |
| E.r. Squibb & Sons, L.L.C. | 34 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $432 |
| Sunovion Pharmaceuticals Inc. | 36 | $340 |
| Vanda Pharmaceuticals Inc. | 9 | $292 |
| Axsome Therapeutics, Inc. | 11 | $247 |
| Ironshore Pharmaceuticals Inc. | 13 | $234 |
| Neos Therapeutics, LP | 11 | $177 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $141 |
| Corium, LLC | 7 | $136 |
| Almatica Pharma LLC | 7 | $115 |
| Noven Therapeutics, LLC | 6 | $113 |
| Supernus Pharmaceuticals, Inc. | 5 | $103 |
| Eisai Inc. | 5 | $94 |
| Vertical Pharmaceuticals, LLC | 3 | $59 |
| Avanir Pharmaceuticals, Inc. | 3 | $56 |
| Indivior Inc. | 2 | $52 |
| Merck | 3 | $48 |
| OWP Pharmaceuticals, Inc. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Adlon Therapeutics L.p. | 2 | $24 |
| Tris Pharma Inc | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Tempus AI, Inc | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,874
- ARISTADA$445
- SPRAVATO$349
- INVEGA TRINZA$248
- INGREZZA$233
- INVEGA SUSTENNA$125
- ABILIFY MAINTENA$123
- COBENFY$122
- Fanapt$120
- ARISTADA INITIO$111
- Auvelity$100
How this compares
$16,174 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 28 | $242,927 |
| Invega TrinzaPaliperidone Palmitate | 15 | $108,475 |
| RexultiBrexpiprazole | 44 | $69,039 |
| VraylarCariprazine Hcl | 19 | $26,641 |
| LybalviOlanzapine/Samidorphan Malate | 12 | $22,955 |
| TrintellixVortioxetine Hydrobromide | 25 | $18,654 |
| ClozarilClozapine | 12 | $16,595 |
| SpravatoEsketamine Hcl | 13 | $16,007 |
| BelsomraSuvorexant | 24 | $10,346 |
| Lurasidone Hcl | 43 | $5,238 |
| Aripiprazole | 92 | $4,541 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 41 | $4,176 |
| Quetiapine Fumarate | 248 | $3,944 |
| Buspirone Hcl | 118 | $2,127 |
| Gabapentin | 141 | $2,083 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,378 | $242,92728 claims |
| Johnson & JohnsonInvega Trinza, Spravato | $2,090 | $124,48228 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,813 | $69,03944 claims |
| AbbVieVraylar | $1,728 | $26,64119 claims |
| Alkermes, Inc.Lybalvi | $1,619 | $22,95512 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $432 | $18,65425 claims |
| MerckBelsomra | $48 | $10,34624 claims |
| Almatica Pharma LLCSertraline Hcl | $115 | $781100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Flower Mound
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.